Cloudberries ( Rubus chamaemorus ) contain phenolics (mainly ellagitannins), which have recently been related to many valuable bioactivity properties. In general, phenolics are known to react readily with various components, which may create an obstacle in producing stable functional components for food and pharmaceutical purposes. In this study, the aim was to improve the storage stability of cloudberry phenolic extract by microencapsulation. The phenolic-rich cloudberry extract was encapsulated in maltodextrins DE5-8 and DE18.5 by freeze-drying. Water sorption properties and glass transition temperatures (T(g)) of microcapsules and maltodextrins were determined. Microcapsules together with unencapsulated cloudberry extract were stored at different relative vapor pressures (0, 33, and 66% RVP) at 25 degrees C for 64 days, and storage stability was evaluated by analyzing phenolic content and antioxidant activity. Compared to maltodextrin DE18.5, maltodextrin DE5-8 had not only higher encapsulation yield and efficiency but also offered better protection for phenolics during storage. Without encapsulation the storage stability of cloudberry phenolics was weaker with higher storage RVP. Microencapsulation improved the storage stability of cloudberry phenolics. The physical state of microcapsules did not have a significant role in the stability of cloudberry phenolics because phenolic losses were observed also in amorphous glassy materials. The antioxidant activity of the microencapsulated cloudberry extract remained the same or even improved slightly during storage, which may be related to the changes in phenolic profiles.
Capsules Drug Compounding